In one paragraphArticle in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
- Comment on
- Comment on
- Comment on
5 · Who and what moneyAuthors and funding
5 authors.
Jedd D WolchokJedd D. Wolchok, MD, PhD, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Harriet Kluger, MD, Yale University School of Medicine, New Haven, CT; Federico Campigotto, MS, Bristol Myers Squibb, Princeton, NJ; James Larkin, MD, PhD, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom; and F. Stephen Hodi, MD, Dana-Farber Cancer Institute, Boston, MA.ORCID 0000-0001-6718-2222 Harriet KlugerJedd D. Wolchok, MD, PhD, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Harriet Kluger, MD, Yale University School of Medicine, New Haven, CT; Federico Campigotto, MS, Bristol Myers Squibb, Princeton, NJ; James Larkin, MD, PhD, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom; and F. Stephen Hodi, MD, Dana-Farber Cancer Institute, Boston, MA.ORCID 0000-0002-4932-9873 Federico CampigottoJedd D. Wolchok, MD, PhD, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Harriet Kluger, MD, Yale University School of Medicine, New Haven, CT; Federico Campigotto, MS, Bristol Myers Squibb, Princeton, NJ; James Larkin, MD, PhD, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom; and F. Stephen Hodi, MD, Dana-Farber Cancer Institute, Boston, MA.
James LarkinJedd D. Wolchok, MD, PhD, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Harriet Kluger, MD, Yale University School of Medicine, New Haven, CT; Federico Campigotto, MS, Bristol Myers Squibb, Princeton, NJ; James Larkin, MD, PhD, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom; and F. Stephen Hodi, MD, Dana-Farber Cancer Institute, Boston, MA.ORCID 0000-0001-5569-9523 F Stephen HodiJedd D. Wolchok, MD, PhD, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Harriet Kluger, MD, Yale University School of Medicine, New Haven, CT; Federico Campigotto, MS, Bristol Myers Squibb, Princeton, NJ; James Larkin, MD, PhD, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom; and F. Stephen Hodi, MD, Dana-Farber Cancer Institute, Boston, MA.ORCID 0000-0001-6825-091X Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4MNCI NIH HHS P30 CA008748
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID35258992
PMCPMC9084429
What OpenQuestion holds
Textmetadata
Read underepoch 390